(Q32040835)

5 July 2017

title

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study (English)

1 reference

5 July 2017

0 references

1 reference

1

J S Skyler

1 reference

5 July 2017

W T Cefalu

2

1 reference

5 July 2017

I A Kourides

3

1 reference

5 July 2017

W H Landschulz

4

1 reference

5 July 2017

C C Balagtas

5

1 reference

5 July 2017

S L Cheng

6

1 reference

5 July 2017

R A Gelfand

7

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

357

1 reference

5 July 2017

issue

9253

1 reference

5 July 2017

page(s)

331-335

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

The quest for normoglycaemia: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Intensive insulin therapy for treatment of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Insulin across respiratory mucosae by aerosol delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

1 reference

7 January 2021

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Insulin Pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Absorption kinetics and biologic effects of subcutaneously injected insulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903638-2

1 reference

7 January 2021

10.1016/S0140-6736(00)03638-2

Identifiers

DOI

1 reference

5 July 2017

1 reference